Patients 0 8 0 8 O
presenting 9 19 9 19 O
with 20 24 20 24 O
a 25 26 25 26 O
CNS 27 30 27 30 B-cancer
tumor 31 36 31 36 I-cancer
presumed 37 45 37 45 O
to 46 48 46 48 O
be 49 51 49 51 O
resectable 52 62 52 62 O
and 63 66 63 66 O
are 67 70 67 70 O
at 71 73 71 73 O
risk 74 78 74 78 O
for 79 82 79 82 O
local 83 88 83 88 O
recurrence 89 99 89 99 O
on 100 102 100 102 O
pre 103 106 103 106 O
- 106 107 106 107 O
operative 107 116 107 116 O
assessment 117 127 117 127 O

Patients 0 8 128 136 O
who 9 12 137 140 O
due 13 16 141 144 O
to 17 19 145 147 O
severe 20 26 148 154 O
claustrophobia 27 41 155 169 B-chronic_disease
can 42 45 170 173 O
not 45 48 173 176 O
tolerate 49 57 177 185 O
MRI 58 61 186 189 O
scanning 62 70 190 198 O

Patients 0 8 199 207 O
with 9 13 208 212 O
a 14 15 213 214 O
known 16 21 215 220 O
allergy 22 29 221 228 O
or 30 32 229 231 O
hypersensitivity 33 49 232 248 O
to 50 52 249 251 O
MRI 53 56 252 255 B-allergy_name
contrast 57 65 256 264 I-allergy_name
agents 66 72 265 271 I-allergy_name
including 73 82 272 281 O
gadolinium 83 93 282 292 B-allergy_name

Pregnant 0 8 293 301 B-pregnancy
women 9 14 302 307 B-gender
as 15 17 308 310 O
determined 18 28 311 321 O
by 29 31 322 324 O
urinary 32 39 325 332 B-clinical_variable
or 40 42 333 335 I-clinical_variable
serum 43 48 336 341 I-clinical_variable
beta 49 53 342 346 I-clinical_variable
hCG 54 57 347 350 I-clinical_variable
within 58 64 351 357 O
72 65 67 358 360 B-upper_bound
hours 68 73 361 366 I-upper_bound
of 74 76 367 369 O
surgery 77 84 370 377 B-treatment

Subjects 0 8 378 386 O
with 9 13 387 391 O
a 14 15 392 393 O
history 16 23 394 401 O
of 24 26 402 404 O
iodide 27 33 405 411 B-allergy_name
allergies 34 43 412 421 O

